File:Carolyn Rodriguez at World Economic Forum.jpg
Size of this preview: 685 × 599 pixels. Other resolutions: 274 × 240 pixels | 549 × 480 pixels | 878 × 768 pixels | 1,185 × 1,037 pixels.
Original file (1,185 × 1,037 pixels, file size: 150 KB, MIME type: image/jpeg)
Summary
| Description | English: The promise of ketamine as a rapid acting treatment for anxiety disorders | Carolyn Rodriguez
Low doses of ketamine seem able to dramatically improve obsessive-compulsive disorder, which has so far proved hard to treat. Carolyn Rodriguez’s lab at Stanford is seeking to understand how it works, with the hope of developing next-generation treatments that do not have ketamine’s side effects.
|
| Date | |
| Source | The promise of ketamine as a rapid acting treatment for anxiety disorders | Carolyn Rodriguez at 2:02 |
| Author | World Economic Forum |
Licensing
.svg){kind=icon}
This video, screenshot or audio excerpt was originally uploaded on YouTube under a CC license.
Their website states: "YouTube allows users to mark their videos with a Creative Commons CC BY license."
To the uploader: You must provide a link (URL) to the original file and the authorship information if available.
This file is licensed under the Creative Commons Attribution 3.0 Unported license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
|
This file, which was originally posted to
The promise of ketamine as a rapid acting treatment for anxiety disorders | Carolyn Rodriguez at 2:02, was reviewed on 25 August 2021 by reviewer Leoboudv, who confirmed that it was available there under the stated license on that date. |
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 15:30, 6 August 2021 | | 1,185 × 1,037 (150 KB) | GRuban | {{Information |description={{en|1=The promise of ketamine as a rapid acting treatment for anxiety disorders {{!}} Carolyn Rodriguez Low doses of ketamine seem able to dramatically improve obsessive-compulsive disorder, which has so far proved hard to treat. Carolyn Rodriguez’s lab at Stanford is seeking to understand how it works, with the hope of developing next-generation treatments that do not have ketamine’s side effects. http://www.weforum.org/ #WorldEconomicForum #Davos}} |date=2019-... |
File usage
The following 2 pages use this file:
